InvestorsHub Logo
Followers 40
Posts 4472
Boards Moderated 0
Alias Born 02/28/2018

Re: FACT-MASTER post# 109444

Sunday, 04/10/2022 7:22:18 PM

Sunday, April 10, 2022 7:22:18 PM

Post# of 113754
We are talking mRNA Bro. The neat thing about that tech is it moves Quick.

How you think they got a covid Vac approved for EU so quickly. Many says it take 4 to 5 years to develop a vaccine. Not with mRNA.

Sunshine through out a hint July 2021

“SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has succeeded in inhibiting the activity of Nrf2 using mRNA vaccine technology. Nrf2 is a transcription factor responsible for activation of oxidative stress genes as well as the cancer multidrug resistance genes, MDR1 (p-Glycoprotein), MRP1 and BCRP. By temporarily inhibiting Nrf2 activity with an mRNA injection immediately before or during chemotherapy, the Company hopes to achieve enhanced performance of anticancer drugs and consequently better overall therapeutic
outcomes for cancer patients. In separate studies using a small molecule inhibitor of Nrf2, the Company results showed that the activity of a test anticancer drug (Etoposide) was enhanced approximately 4-fold. These studies were performed in MCF-7/MDR, a multidrug resistant
breast cancer cell line



IMO of course. It not a new effort its ongoing mRNA research more than a year in development.


Buy More $SBFM Its a Cancer and COVID Killer

But do Your Own DD

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News